Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Albendazole /Ivermectin Tablet bulk supplier for pharma manufacturers

Albendazole /Ivermectin Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 400mg+ 12mg

Reference Brands: Various Indian Brand Available

Category: Anthelmintic

This anti-worm medicine kills infestations such as tapeworm and roundworms in animals. Albendazole and Ivermectin suspension absorbs the body's energy and works by paralyzing the worms and leading to their death eventually.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Albendazole + Ivermectin Tablets are combination antiparasitic medications used for the treatment of a broad range of intestinal worm infections. This formulation combines albendazole, a benzimidazole derivative that works by inhibiting glucose uptake in parasites, leading to depletion of their energy stores, with ivermectin, a macrocyclic lactone that interferes with the parasite’s nervous system, causing paralysis and eventual death. Together, they provide enhanced efficacy through dual mechanisms of action.

This combination is commonly used to treat infections caused by roundworms, hookworms, whipworms, and other intestinal parasites, and is particularly useful in mixed or heavy infestations where single-drug therapy may not be sufficient. It is also considered in certain parasitic conditions such as strongyloidiasis.

Albendazole + Ivermectin Tablets are widely used in regions with high prevalence of parasitic infections. They should be taken as prescribed by a healthcare professional, with proper adherence to dosage and duration to ensure complete eradication of parasites and to reduce the risk of recurrence or resistance.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Albendazole / Ivermectin Tablets are used to treat a wide range of parasitic infections, including intestinal worms such as roundworms, hookworms, whipworms, and strongyloidiasis. The combination is particularly useful in mixed or resistant infections.

Albendazole / Ivermectin Tablets are made from albendazole, which inhibits glucose uptake in parasites leading to energy depletion, and ivermectin, which acts on the parasite’s nervous system causing paralysis and death.

The trade names include Iverzole, Ziverdo, Iverheal-AB, and other region-specific brands.

This combination is manufactured by multiple pharmaceutical companies, especially in India and export markets. Examples include Healing Pharma (Iverheal-AB), and other Indian manufacturers producing similar combinations for domestic and international markets.

The generic name is albendazole and ivermectin.

The brand names include Iverzole, Ziverdo, Iverheal-AB, and other regional brands.

Albendazole / Ivermectin Tablets are primarily manufactured in India and other emerging markets for domestic use and export, as this combination is not widely approved in regulated markets like the USA and EU.

Related Products

Chloroquine Phosphate

Strength:
100 mg , 150 mg , 200 mg , 250 mg , 40 mg/ml

Form: Tablets / injection

Reference Brands: Aralen (USA), Nivaquine (EU), Lariago (India)

View Details
Triclabendazole

Strength:
250 mg

Form: Tablets

Reference Brands: Egaten (USA/EU), Fasigyl (EU)

View Details
Mefloquine Hydrochloride

Strength:
250 mg

Form: Tablets

Reference Brands: Lariam (USA/EU)

View Details
Diethylcarbamazine (Dec) Tablet

Strength:
100 mg

Form: Tablets

Reference Brands: Generic formulations available in various generic brands

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.